Related Experiment Video
Updated: Sep 10, 2025

07:44
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
1.3K
Commentary: Improving the vaccination experience for children and adults
Cynthia M Rand1, Peter G Szilagyi2,3
1Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA.
Human Vaccines & Immunotherapeutics
|August 25, 2025
Summary
Vaccine anxiety affects many children and adults, leading to avoidance. The CARD system empowers patients with coping strategies, improving the vaccination experience for everyone involved.
Area of Science:
- Medical Social Sciences
- Public Health
- Patient Experience
Background:
- Significant vaccination anxiety affects two out of three children and one out of four adults.
- Vaccine anxiety can lead to vaccine avoidance, impacting public health outcomes.
- Current approaches may not adequately address patient-centered needs during vaccination.
Purpose of the Study:
- To introduce and evaluate the CARD system as a patient-centered approach to vaccination.
- To explore how promoting patient autonomy in choosing coping strategies can improve vaccination experiences.
- To assess the impact of the CARD system on both patients and healthcare providers.
Main Methods:
- The study likely involved the implementation and assessment of the CARD system in a clinical or research setting.
- Methods may include surveys, interviews, or observational data collection to gauge patient and provider experiences.
- Focus on patient-centered care and autonomy in selecting coping mechanisms.
Main Results:
- The CARD system is presented as an innovative approach that enhances the vaccination experience.
- Positive outcomes are suggested for both patients (reduced anxiety, improved experience) and healthcare providers (smoother process).
- Empowering patients with choices is key to improving vaccination encounters.
Conclusions:
- The CARD system offers a promising, patient-centered solution to mitigate vaccine anxiety.
- Enhancing patient autonomy through tailored coping strategies can significantly improve vaccination acceptance and experience.
- This approach benefits both individuals seeking vaccination and the healthcare professionals administering them.
Related Concept Videos
Vaccinations
45.3K
Overview
45.3K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Active versus Passive Immunity
3.7K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
3.7K
Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314
Development of Immunocompetence
448
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
448
Immunological Memory
4.8K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
4.8K

